Bristol-Myers Squibb Company - Asset Resilience Ratio

Latest as of December 2025: 4.35%

Bristol-Myers Squibb Company (BMY) has an Asset Resilience Ratio of 4.35% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read BMY current and long-term liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

$464.00 Million

Cash + Short-term Investments

Total Assets

$10.67 Billion

All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (1999–2024)

This chart shows how Bristol-Myers Squibb Company's Asset Resilience Ratio has changed over time. See Bristol-Myers Squibb Company (BMY) shareholders funds for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Bristol-Myers Squibb Company's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see BMY stock market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$464.00 Million	4.35%
Total Liquid Assets	$464.00 Million	4.35%

Asset Resilience Insights

Limited Liquidity: Bristol-Myers Squibb Company maintains only 4.35% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Bristol-Myers Squibb Company Industry Peers by Asset Resilience Ratio

Compare Bristol-Myers Squibb Company's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
AstraZeneca PLC MX:AZNN	Drug Manufacturers - General	0.03%
Pfizer Inc NYSE:PFE	Drug Manufacturers - General	7.18%
Novartis AG SW:NOVN	Drug Manufacturers - General	10.04%
Pfizer Inc SA:PFIZ34	Drug Manufacturers - General	7.18%
Virbac SA PA:VIRP	Drug Manufacturers - General	0.23%
Hubei Guangji Pharmaceutical Co Ltd SHE:000952	Drug Manufacturers - General	5.37%
Firebrick Pharma Ltd AU:FRE	Drug Manufacturers - General	0.29%
Eli Lilly and Company SA:LILY34	Drug Manufacturers - General	8.63%

Annual Asset Resilience Ratio for Bristol-Myers Squibb Company (1999–2024)

The table below shows the annual Asset Resilience Ratio data for Bristol-Myers Squibb Company.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	11.73%	$10.86 Billion	$92.60 Billion	-1.18pp
2023-12-31	12.90%	$12.28 Billion	$95.16 Billion	+3.35pp
2022-12-31	9.56%	$9.25 Billion	$96.82 Billion	-6.20pp
2021-12-31	15.75%	$17.22 Billion	$109.31 Billion	+1.87pp
2020-12-31	13.88%	$16.45 Billion	$118.48 Billion	+2.04pp
2019-12-31	11.85%	$15.39 Billion	$129.94 Billion	-13.19pp
2018-12-31	25.04%	$8.76 Billion	$34.99 Billion	+4.73pp
2017-12-31	20.30%	$6.81 Billion	$33.55 Billion	+1.46pp
2016-12-31	18.84%	$6.35 Billion	$33.71 Billion	+12.90pp
2015-12-31	5.94%	$1.89 Billion	$31.75 Billion	+0.41pp
2014-12-31	5.52%	$1.86 Billion	$33.75 Billion	+3.09pp
2013-12-31	2.43%	$939.00 Million	$38.59 Billion	-0.83pp
2012-12-31	3.27%	$1.17 Billion	$35.90 Billion	-5.70pp
2011-12-31	8.97%	$2.96 Billion	$32.97 Billion	+1.67pp
2010-12-31	7.30%	$2.27 Billion	$31.08 Billion	+4.62pp
2009-12-31	2.68%	$831.00 Million	$31.01 Billion	+1.70pp
2008-12-31	0.98%	$289.00 Million	$29.49 Billion	-0.64pp
2007-12-31	1.62%	$424.00 Million	$26.17 Billion	-6.18pp
2006-12-31	7.80%	$2.00 Billion	$25.57 Billion	-1.97pp
2005-12-31	9.77%	$2.75 Billion	$28.14 Billion	-2.70pp
2004-12-31	12.47%	$3.79 Billion	$30.43 Billion	+1.49pp
2003-12-31	10.98%	$3.01 Billion	$27.45 Billion	+4.49pp
2002-12-31	6.48%	$1.62 Billion	$25.02 Billion	+5.91pp
2001-12-31	0.57%	$154.00 Million	$27.06 Billion	-0.59pp
2000-12-31	1.15%	$203.00 Million	$17.58 Billion	-0.23pp
1999-12-31	1.38%	$237.00 Million	$17.11 Billion	--

pp = percentage points

About Bristol-Myers Squibb Company

NYSE:BMY USA Drug Manufacturers - General

Market Cap

$114.51 Billion

Market Cap Rank

#204 Global

#108 in USA

Share Price

$56.25

Change (1 day)

-0.60%

52-Week Range

$42.60 - $62.37

All Time High

$74.57